Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Natus Sensory is a global leader in sensory diagnostics and neurodiagnostic healthcare solutions, specializing in hearing, balance, vision, and newborn care. Headquartered in Schaumburg, Illinois, and Copenhagen, Denmark, the company was established as a standalone entity in 2022 following the strategic split of Natus Medical Incorporated by private equity firm ArchiMed. Natus Sensory provides a comprehensive portfolio of advanced diagnostic equipment and software, including hearing assessment systems, pediatric screening tools, and jaundice management solutions, serving healthcare providers in over 120 countries. The company's mission is to improve patient outcomes through innovation, clinical education, and comprehensive technical support. Recently, Natus Sensory has expanded its technological capabilities through the acquisitions of TheraB Medical and Keriton, strengthening its leadership in neonatal care and audiology.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Natus Sensory.